The PARTNER Act amends the International Organizations Immunities Act (IOIA) to extend the United States privileges and immunities to five additional international and regional organizations: the Association of Southeast Asian Nations (ASEAN), the European Organization for Nuclear Research (CERN), the Pacific Islands Forum, the Caribbean Community, and the African Union. The extensions would be issued under terms and conditions determined by the President, and would apply to participation or activities of these organizations in the United States in the same manner as existing public international organizations to which the United States participates under treaty or appropriations authority.
The bill also revises IOIA to include the African Union permanent observer mission to the United Nations in New York within the scope of the immunities. This is a straightforward expansion of immunities, not a funding or governance change, but it shapes how these bodies and their staff can operate on U.S. soil and in U.S.-led forums.
At a Glance
What It Does
The President may extend IOIA privileges and immunities to ASEAN, CERN, the Pacific Islands Forum, the Caribbean Community, and the African Union under terms similar to those already extended to other public international organizations.
Who It Affects
Member states and staff of these bodies, their missions in the United States, and U.S. agencies interacting with them.
Why It Matters
This creates a uniform framework for immunities across additional international bodies, potentially smoothing diplomacy and scientific collaboration while raising questions about accountability and domestic enforcement.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill adds five international organizations to the list of entities that can receive United States privileges and immunities under the IOIA. It does so by authorizing the President to extend these immunities to ASEAN, CERN, the Pacific Islands Forum, the Caribbean Community, and the African Union, on terms that mirror the treatment given to other public international organizations in which the United States participates.
In practice, this means the organizations’ missions, staff, properties, and activities in the United States would enjoy immunity from certain kinds of legal processes, under conditions set by the President and in line with existing treaties or Congress-approved participation. A notable change is the explicit inclusion of the African Union permanent observer mission to the United Nations in New York and its members within the scope of these immunities.
The bill thus broadens the field of entities that the United States can shield from certain liabilities, in service of facilitating participation in U.S. and international forums and cooperation, while leaving administration and oversight to executive discretion and existing statutory structures.
The Five Things You Need to Know
The bill adds five organizations to IOIA immunity coverage: ASEAN, CERN, Pacific Islands Forum, Caribbean Community, and African Union.
Immunities extend under terms determined by the President, using the same framework as other public international organizations.
AU changes include extending immunities to the AU permanent observer mission to the United Nations (New York) and its members.
Immunities relate to participation and activities in which the U.S. participates, governed by treaties or Acts authorizing such participation or funding.
This is a policy extension without fresh funding or governance mandates; it emphasizes admission of more bodies into the immunity regime.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Extension to ASEAN
Section 2 adds a new IOIA section 18 authorizing the President to extend IOIA privileges and immunities to the Association of Southeast Asian Nations. The extension would be on the same terms, extent, and conditions as other United States participations in public international organizations, as determined by treaty or applicable law. The practical effect is to shield ASEAN and its staff and activities in the United States from certain legal processes, subject to the same kind of bilateral or multilateral agreements that govern other immunized bodies.
Extension to CERN
Section 3 adds IOIA section 19 enabling the President to extend the IOIA immunities to CERN under the same structure used for other international organizations. CERN’s operations in the United States and its personnel would, under terms set by the President, gain the immunities that accompany U.S. participation in comparable bodies, aligning CERN’s U.S. presence with existing immunized organizations.
Extension to Pacific Islands Forum
Section 4 creates IOIA section 20 to extend privileges and immunities to the Pacific Islands Forum. The mechanism mirrors existing practice for other organizations, allowing the President to determine terms and conditions under which the Forum and its staff are immune in the United States, facilitating its activities and participation in U.S.-led or hosted initiatives.
Extension to Caribbean Community
Section 5 adds IOIA section 21 to extend immunities to the Caribbean Community. The extension follows the same model as other immunized organizations, with the President empowered to set terms, so that the Community’s missions and personnel can operate within the United States with appropriate immunities under the IOIA framework.
Extension to African Union and UN mission
Section 6 amends IOIA section 12(b) to broaden the scope to include the African Union Mission to the United Nations in New York and its members, extending authorities and obligations on the same terms and under corresponding conditions. It also clarifies that the AU permanent observer mission to the UN and its members enjoy the privileges and immunities consistent with Permanent Missions to the United Nations.
This bill is one of many.
Codify tracks hundreds of bills on Foreign Affairs across all five countries.
Explore Foreign Affairs in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- ASEAN member state governments and their diplomatic missions benefit from smoother operations and reduced liability exposure in the United States, aiding diplomacy and regional collaboration.
- CERN and its international staff benefit from immunities that facilitate multinational research activities and the U.S. role in global science partnerships.
- Pacific Islands Forum member states gain easier access to U.S.-facilitated programs and forums, with reduced legal friction for their delegations and personnel.
- Caribbean Community member states gain a more predictable legal framework for participating in U.S.-hosted regional initiatives and international cooperation.
- The African Union and its permanent observer mission to the United Nations in New York gain immunities that support ongoing multilateral diplomacy within U.S. settings.
Who Bears the Cost
- U.S. taxpayers may bear indirect costs associated with funding and oversight of the expanded immunities regime.
- U.S. courts and legal systems may encounter altered dynamics in cases involving immunized international bodies or their personnel, potentially limiting remedies for private parties.
- U.S. government agencies (eg State Department) will take on additional oversight and coordination duties to manage the immunities extensions and ensure compliance with related laws and treaties.
- Domestic entities and individuals seeking redress against immunized organizations could face reduced avenues for civil liability or damages when interacting with these bodies.
Key Issues
The Core Tension
The central question is whether extending immunities to additional international organizations streamlines cooperation and upholds U.S. strategic interests, while potentially reducing accountability and remedies available to private actors within the United States.
Extending immunities to ASEAN, CERN, the Pacific Islands Forum, the Caribbean Community, and the African Union under IOIA improves diplomatic and scientific collaboration by reducing legal frictions for those bodies on U.S. soil. However, immunities can limit accountability and civil remedies, and the executive branch gains broad discretion to define terms and scope.
The bill does not alter funding levels or create new enforcement mechanisms; it relies on the President to determine participation terms, subject to existing treaty and Congressional authorization pathways, which could create variability across organizations and over time. Questions remain about how immunities will interact with U.S. anti-corruption, anti-terrorism, and sanctions laws, and how disputes involving immunized bodies will be resolved when U.S. law and international immunities intersect.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.